Senior Director, Associate General Counsel, Launch Readiness and Commercial Execution, Europe

Das ist der Job

The company’s RD pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.

Darum lohnt es sich

As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The critical role will also support commercialization readiness for initial European and other product launches, including review of promotional, medical education and disease awareness materials in accordance with applicable EU and national laws, EMA guidance, EFPIA and national industry codes and internal policies as well as general support across the European Legal team as business needs evolve.

As a key senior member of the European Legal Team, you will have significant visibility, influence and the opportunity to shape both the European legal function and the company’s launch strategy during a transformational period of growth. Support launch governance and serve as a senior legal representative on European launch teams.

Coordinate legal support across headquarters, regional and local teams to ensure consistent execution. Leadership Team Management Lead, develop and mentor a team of five local market attorneys across major European markets. Establish clear priorities, objectives and development plans for team members.

Foster collaboration across regional and local legal teams and build a culture of accountability, excellence and inclusion. Collaborate closely with Medical Affairs, Regulatory, Compliance, Pharmacovigilance, Government Affairs, Market Access and Commercial Excellence teams. Experience leading geographically dispersed legal teams.

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers.

The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.

The Opportunity Revolution Medicines is seeking an experienced and business‑oriented Senior Attorney to support our European Commercial Organisation’s rapid build‑out and scale‑up to the European Launch of Daraxonrasib and beyond.

This highly strategic leadership position will focus on managing and leading local attorneys in five key markets, forming a Business Partnering relationship with the in‑market GMs and the regional head, drafting and negotiating a broad range of commercial agreements, with particular emphasis initially on Market Access, Early Access Programmes and Launch Readiness.

The ideal candidate will bring excellent leadership, commercial contracting, launch preparation and market access experience within the biotechnology, pharmaceutical or life sciences industry and demonstrate sound judgment, pragmatism and the ability to operate effectively and at times independently in a fast‑paced, collaborative environment.

This is a unique opportunity to play a pivotal role in bringing an innovative oncology medicine to patients across Europe. You will join a growing, mission‑driven biotechnology company at a defining stage in its evolution, partnering with exceptional colleagues and helping build the legal foundations for long‑term commercial success.

Key Responsibilities European Launch Readiness Lead legal support for European launch readiness activities for the company's first oncology product. Develop and execute the European legal launch strategy in partnership with cross‑functional leadership.

Identify legal risks that may impact launch timelines and develop pragmatic mitigation strategies. Commercialisation Act as a key commercial legal adviser to the European Commercial organisation. Provide strategic legal advice on commercial operations, promotional activities and product commercialisation.

Advise on customer engagement, contracting strategies, and commercial initiatives. Review and negotiate complex commercial agreements, including services, procurement, collaboration and strategic partnership agreements. Ensure commercial activities comply with applicable European and local legal requirements.

Market Access Pricing Provide legal support for European and country‑level market access strategies. Advise on pricing, reimbursement, tendering, payer engagement and health technology assessment activities. Counsel business stakeholders on competition law, interactions with government bodies and applicable healthcare regulations.

Support innovative access models and commercial arrangements while balancing legal and business considerations. Promote consistency in legal advice while recognising local legal and commercial requirements. Support talent development, succession planning and organisational growth within the European Legal function.

Strategic Business Partnership Serve as a trusted adviser to senior European leadership. Balance legal risk with commercial objectives in a fast‑paced, entrepreneurial environment. Contribute to broader European Legal strategy and operational excellence initiatives. Support future product launches and portfolio expansion across Europe.

Required Skills, Experience and Education 15 year+ qualified lawyer with the right to practise in a European jurisdiction. Significant post‑qualification legal experience, including substantial experience within the pharmaceutical or biotechnology industry.

Demonstrated success supporting multiple European and UK product launches, ideally including first‑in‑Europe/UK launches. Deep expertise in European pharmaceutical commercialisation, launch readiness and market access. Strong knowledge of European pharmaceutical laws, healthcare regulations, competition law and industry codes.

Proven ability to influence senior executives and operate effectively within complex matrix organisations. Excellent commercial judgement with a pragmatic, solutions‑oriented approach. Outstanding communication, negotiation and stakeholder management skills. Fluent English; additional European languages are advantageous.

Willingness to travel across Europe as required. Preferred Skills Experience within oncology or specialty pharmaceuticals. Experience in an early‑stage or high‑growth biotechnology company. Familiarity with pricing and reimbursement frameworks across major European markets.

Experience building legal processes and capabilities in a rapidly scaling organisation.